Skip to main content

Pathobiological Role of CRP in Diseases: Clinical Medical Applications of CRP

  • Chapter
  • First Online:
Biology of C Reactive Protein in Health and Disease
  • 1126 Accesses

Abstract

Although C-reactive protein has been designated as a marker for inflammation and recently as a marker in assessment of risk in cardiovascular disorders from a number of studies across the globe, the role of CRP in other diseases have also been studied. Some of the major diseases in which CRP levels have been correlated with disease states are detailed in this chapter. Bearing a hepatic origin, C-reactive protein is a protein found in the plasma and belongs to the pentraxin family participating in the inflammatory reaction. The CRP concentration in response to injury or infection becomes escalated about 1000-fold over and above normally expressed levels. CRP is known for its function as a mediator in the classical innate immunity pathway and constitutes a part of both humoral and cellular effector systems of inflammation. Although it is well known as a marker for acute-phase response in injury of the tissue, during the infection of the host by pathogenic agents like viruses, bacteria, parasites, and inflammations, it has recently gained the status of a disease marker in cardiovascular disorders and also has been reported for its clinical and pathological significance. In this chapter we highlight the status of C-reactive protein (CRP) in different disorders and pathological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Allin KH, Nordestgaard BG, Flyger H, Bojesen SE (2011) Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res 13:R55

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ansar W, Bandyopadhyay SM, Chowdhury S, Habib SH, Mandal C (2006) Role of C-reactive protein in complement mediated hemolysis in Malaria. Glycoconj J 23(3–4):233–240

    Article  CAS  PubMed  Google Scholar 

  • Ansar W, Habib SK, Roy S, Mandal C, Mandal C (2009a) Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria. Cell Physiol Biochem 23(1–3):175–190. doi:10.1159/000204106. Epub 2009 Feb 18

    Article  CAS  PubMed  Google Scholar 

  • Asgari SA, Mokhtari G, Falahatkar S, Mansour-Ghanaei M, Roshani A, Zare A, Zamani M, Khosropanah I, Salehi M (2006) Diagnostic accuracy of C-reactive protein and erythrocyte sedimentation rate in patients with acute scrotum. Urol J 3(2):104–108

    PubMed  Google Scholar 

  • Autelitano DJ, Raineri L, Knight K, Bannister K, Rice GE (2012) Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women. J Transl Med 10:45

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bilgir O, Bilgir F, Topcuoglu T, Calan M, Calan O (2014) Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism. Endocrine 45(2):244–248

    Article  CAS  PubMed  Google Scholar 

  • Cheng Q, Xia W, Yang S, Ye P, Mei M, Song Y, Luo M, Li Q (2013) Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome. J Endocrinol Investig 36(8):632–635

    Article  CAS  Google Scholar 

  • Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 166(2):379–386

    Article  CAS  PubMed  Google Scholar 

  • Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17:1019–1025

    Article  CAS  PubMed  Google Scholar 

  • Czarnywojtek A, Owecki M, Zgorzalewicz-Stachowiak M, WoliÅ„ski K, Szczepanek-Parulska E, Budny B, Florek E, Waligórska-Stachura J, Miechowicz I, BÄ…czyk M, Sawicka N, Dhir S, RuchaÅ‚a M (2014) The role of serum C-reactive protein measured by high-sensitive method in thyroid disease. Arch Immunol Ther Exp (Warsz) 62(6):501–509

    Article  CAS  Google Scholar 

  • Das UN (2001) Is obesity an inflammatory condition? Nutrition 17:953–966

    Article  CAS  PubMed  Google Scholar 

  • Das T, Sen A, Kempf T, Pramanik SR, Mandal C, Mandal C (2003) Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J 373(Pt 2):345–355

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Beer FC, Shine B, Pepys MB (1982a) Radiometric ligand binding assay for C-reactive protein. Complexed C reactive protein is not detectable in acute-phase serum. Clin Exp Immunol 50:231–237

    PubMed  PubMed Central  Google Scholar 

  • Deligeoroglou E, Vrachnis N, Athanasopoulos N, Iliodromiti Z, Sifakis S, Iliodromiti S, Siristatidis C, Creatsas G (2012) Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol 28(12):974–978

    Article  CAS  PubMed  Google Scholar 

  • Dobrzycka B, Mackowiak-Matejczyk B, Terlikowska KM, Kulesza-Bronczyk B, Kinalski M, Terlikowski SJ (2013) Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer. Eur Cytokine Netw 24(3):106–113

    CAS  PubMed  Google Scholar 

  • Doehn C, Fornara P, Kausch I, Büttner H, Friedrich HJ, Jocham D (2001) Value of acute-phase proteins in the differential diagnosis of acute scrotum. Eur Urol 39(2):215–221

    Article  CAS  PubMed  Google Scholar 

  • El-Mesallamy HO, Abd El-Razek RS, El-Refaie TA (2013) Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 168(2):178–182

    Article  CAS  PubMed  Google Scholar 

  • Esfahanian F, Zamani MM, Heshmat R, Moini nia F (2013) Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome. J Obstet Gynaecol Res 39(4):806–813

    Article  PubMed  Google Scholar 

  • Gaitonde S, Samols D, Kushner I (2008) C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 59:1814–1820

    Article  CAS  PubMed  Google Scholar 

  • Gasim S, Theander TG, ElHassan AM (2000) High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Trop 75(1):35–38

    Article  CAS  PubMed  Google Scholar 

  • Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462–466

    Article  CAS  PubMed  Google Scholar 

  • Hirschfield GM, Pepys MB (2003) C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 96:793–807

    Article  CAS  PubMed  Google Scholar 

  • Jublanc C, Bruckert E, Giral P, Chapman MJ, Leenhardt L, Carreau V, Turpin G (2004) Relationship of circulating C-reactive protein levels to thyroid status and cardiovascular risk in hyperlipidemic euthyroid subjects: low free thyroxine is associated with elevated hsCRP. Atherosclerosis 172(1):7–11

    Article  CAS  PubMed  Google Scholar 

  • Kaya C, Akgül E, Pabuccu R (2010) C-reactive protein and homocysteine levels are associated with abnormal heart rate recovery in women with polycystic ovary syndrome. Fertil Steril 94(1):230–235

    Article  CAS  PubMed  Google Scholar 

  • King DE, Mainous AG 3rd, Buchanan TA, Pearson WS (2003) C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26:1535–1539

    Article  PubMed  Google Scholar 

  • Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA (2014) Genetic variation across C-reactive protein and risk of prostate cancer. Prostate 74(10):1034–1042. doi:10.1002/pros.22820, Epub 2014 May 20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martocchia A, Cola S, Frugoni P, Indiano I, D’Urso R, Falaschi P (2010) The burden of comorbidity and the C-reactive protein levels in nonthyroidal illness syndrome with metabolic syndrome and atherosclerosis-related cardiovascular complications. Ann N Y Acad Sci 1193:164–166

    Article  CAS  PubMed  Google Scholar 

  • Mugabo Y, Li L, Renier G (2010) The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 6(1):27–34

    Article  CAS  PubMed  Google Scholar 

  • Nagasaki T, Inaba M, Shirakawa K, Hiura Y, Tahara H, Kumeda Y, Ishikawa T, Ishimura E, Nishizawa Y (2007) Increased levels of C-reactive protein in hypothyroid patients and its correlation with arterial stiffness in the common carotid artery. Biomed Pharmacother 61(2–3):167–172, Epub 2007 Feb 21

    Article  CAS  PubMed  Google Scholar 

  • Nebiker CA, Delko T, Zulewski H, Oertli D (2013) Acute thyroid swelling and elevated C reactive protein. BMJ Case Rep 2013. pii: bcr2013200427

    Google Scholar 

  • Niizuma T, Terada K, Kosaka Y, Daimon Y, Inoue M, Ogita S, Kataoka N, Tanaka K (2004) Elevated serum C-reactive protein in mumps orchitis. Pediatr Infect Dis J 23(10):971

    Article  PubMed  Google Scholar 

  • Nowicka MA, Fritz-Rdzanek A, Grzybowski W, Walecka I, Niemiec KT, Jakimiuk AJ (2010) C-reactive protein as the indicator of severity in ovarian hyperstimulation syndrome. Gynecol Endocrinol 26(6):399–403

    Article  CAS  PubMed  Google Scholar 

  • Oliveira EB, Gotschlich EC, Liu T-Y (1979) Primary structure of human C-reactive protein. J Biol Chem 254(2):489–502

    CAS  PubMed  Google Scholar 

  • Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, FossÃ¥ SD (2009) Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun 23(6):868–874

    Article  CAS  PubMed  Google Scholar 

  • Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pepys MB, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW et al (2012) Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use. J Immunol Methods 384:92–102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Piciu A, Piciu D, Marlowe RJ, Irimie A (2013) Highly-sensitive C-reactive protein, a biomarker of cardiovascular disease risk, in radically-treated differentiated thyroid carcinoma patients after repeated thyroid hormone withholding. Exp Clin Endocrinol Diabetes 121(2):102–108

    Article  CAS  PubMed  Google Scholar 

  • Poole EM, Lee IM, Ridker PM, Buring JE, Hankinson SE, Tworoger SS (2013) A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer. Am J Epidemiol 178(8):1256–1264

    Article  PubMed  PubMed Central  Google Scholar 

  • Rezaieyazdi Z, Sahebari M, Hatef MR, Abbasi B, Rafatpanah H, Afshari JT, Esmaily H (2011) Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus? Lupus 20(14):1494–1500

    Article  CAS  PubMed  Google Scholar 

  • Sasidevi A, Vellanki P, Kunselman AR, Raja-Khan N, Dunaif A, Legro RS (2013) Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome. Hum Reprod 28(3):770–776. doi:10.1093/humrep/des416. Epub 2012 Dec

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strati I, Copelovici Y, Selim G (1993) [C-reactive protein (Crp) in different clinical forms of mumps infection]. Rev Roum Virol 44(3–4):305–306

    CAS  PubMed  Google Scholar 

  • Tanigaki K, Vongpatanasin W, Barrera JA, Atochin DN, Huang PL, Bonvini E, Shaul PW, Mineo C (2012) C-reactive protein causes insulin resistance in mice through Fcγ Receptor IIB-mediated inhibition of skeletal muscle glucose delivery. Diabetes 62:721–731

    Article  PubMed  Google Scholar 

  • Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105:564–569

    Article  PubMed  Google Scholar 

  • Ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CG (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17:1642–1648

    PubMed  Google Scholar 

  • Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:169–177

    Article  CAS  PubMed  Google Scholar 

  • Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T (2015) The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer 51(5):610–619. doi:10.1016/j.ejca.2015.01.002. Epub 2015 Jan 21

    Article  CAS  PubMed  Google Scholar 

  • Toriola AT, Grankvist K, Agborsangaya CB, Lukanova A, Lehtinen M, Surcel HM (2011) Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol 22(8):1916–1921

    Article  CAS  PubMed  Google Scholar 

  • Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N (2014) Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol 135(2):297–304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K (2005) Subclinical hypothyroidism may be associated with elevated high-sensitive c-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 52(1):89–94

    Article  CAS  PubMed  Google Scholar 

  • Vogt B, Führnrohr B, Müller R, Sheriff A (2007) CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 40:295–298

    Article  CAS  PubMed  Google Scholar 

  • Wethal T, Haugnes HS, Kjekshus J, SmÃ¥stuen MC, Ueland T, Aukrust P, FossÃ¥ SD (2010) C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? Eur J Cancer 46(18):3425–3433

    Article  CAS  PubMed  Google Scholar 

  • Yu YT, Ho CT, Hsu HS, Li CI, Davidson LE, Liu CS, Li TC, Shih CM, Lin CC, Lin WY (2013) Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese. Endocrine 44(3):716–722

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer India

About this chapter

Cite this chapter

Ansar, W., Ghosh, S. (2016). Pathobiological Role of CRP in Diseases: Clinical Medical Applications of CRP. In: Biology of C Reactive Protein in Health and Disease. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2680-2_6

Download citation

Publish with us

Policies and ethics